Home Home Home Inbox Home Search

Event

Baseline Cystic Fibrosis Transmembrane Conductance Regulator Protein Expression Predicts Subject Response to Lumacaftor-Ivacaftor Treatment [Board No. P770]

Location: Board no. P770
Session Type: Thematic Poster Session
Sunday
May
20
11:15 AM
1:00 PM

Speaker(s)/Author(s)

Peter E. Bialek

PhD
Proteostasis Therapeutics, Inc

Po-Shun Lee

MD
Proteostasis Therapeutics, Inc

Calvin Cotton

PhD
Binnacle Biosciences LLC;Case Western Reserve University

Sheila Wilson

RN
Proteostasis Therapeutics Inc

Gregory S. Sawicki

MPH, MD
Boston Children's Hospital

Brittany McLaughlin

BA
Proteostasis Therapeutics, Inc

Felix A. Ratjen

MD, PhD, FRCP(C)
Hospital for Sick Children;The Hospital for Sick Children

Maneet Singh

PhD
Proteostasis Therapeutics, Inc

Geoffrey S. Gilmartin

MD
Beth Israel Deaconess Medical Ctr;Proteostasis Therapeutics, Inc

Patrick A. Flume

MD
Med Univ of S Carolina;Medical University of South Carolina

View Abstract

Baseline Cystic Fibrosis Transmembrane Conductance Regulator Protein Expression Predicts Subject Response to Lumacaftor-Ivacaftor Treatment

Parent Sessions

  • A72 - WHAT'S NEW IN CYSTIC FIBROSIS, BPD AND OTHER CONGENITAL PEDIATRIC LUNG DISEASES...
    05-20-2018 9:15 AM - 4:15 PM
    • Home Home Home Inbox Home Search